Cargando…
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
A systematic and ordered product development program, in compliance with current quality and regulatory standards, increases the likelihood of yielding a successful advanced therapy medicinal product (ATMP) for clinical use as safe and effective therapy. As this is a novel field, little accurate inf...
Autores principales: | Gastelurrutia, Paloma, Prat-Vidal, Cristina, Vives, Joaquim, Coll, Ruth, Bayes-Genis, Antoni, Gálvez-Montón, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890001/ https://www.ncbi.nlm.nih.gov/pubmed/33614746 http://dx.doi.org/10.3389/fcvm.2021.604434 |
Ejemplares similares
-
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
por: Roura, Santiago, et al.
Publicado: (2017) -
Our Journey Through Advanced Therapies to Reduce Post-Infarct Scarring
por: Roura, Santiago, et al.
Publicado: (2021) -
Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrate
por: Adeliño, Raquel, et al.
Publicado: (2022) -
Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine
por: Prat-Vidal, Cristina, et al.
Publicado: (2013)